Products
Platform
Research
Market
Learn
SMS Pharmaceuticals Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 243.86 | 196.64 | 249.62 | 175.48 | 198.05 |
| Other Income Qtr Cr | 1.43 | 0.59 | 1.42 | 2.13 | 1.30 |
| Operating Revenues Qtr | 242.43 | 196.05 | 248.20 | 173.35 | 196.75 |
Loading chart... | |||||
Operating Expenses Qtr | 194.06 | 156.68 | 207.39 | 140.14 | 165.28 |
Operating Profit Qtr | 48.36 | 39.37 | 40.81 | 33.21 | 31.47 |
EBITDA Qtr Cr | 49.80 | 39.96 | 42.23 | 35.34 | 32.77 |
Depreciation Qtr | 10.02 | 9.75 | 8.64 | 8.70 | 8.62 |
Net Profit Qtr | 25.31 | 20.49 | 20.32 | 18.24 | 14.10 |
Basic EPS Qtr | 2.84 | 2.31 | 2.40 | 2.15 | 1.67 |
Open Demat Account
Open Demat Account